Skip to main content

Original Research

Original Research, Practice Management
Estimating the Real-World Cost of Diabetes Mellitus in the United States During an 8-Year Period Using 2 Cost Methodologies
Vincent J. Willey, PharmD, Sheldon Kong, PhD, Bingcao Wu, MS, Amit Raval, PhD, Todd Hobbs, MD, Andrea Windsheimer, PharmD, Gaurav Deshpande, MS, PhD, Ozgur Tunceli, PhD, Brian Sakurada, PharmD, Jonathan R. Bouchard, MS, RPh
Vincent J. Willey, PharmD; Sheldon Kong, PhD; Bingcao Wu, MS; Amit Raval, PhD; Todd Hobbs, MD; Andrea Windsheimer, PharmD; Gaurav Deshpande, MS, PhD; Ozgur Tunceli, PhD; Brian Sakurada, PharmD; Jonathan R. Bouchard, MS, RPh
Read More
Original Research, Practice Management
The Prevalence and Payer Costs of Potentially Avoidable Emergent Care Visits for Suspected Amniotic Membrane Rupture in Pregnant Women
Christine Ferro, CHFP, Bruce S. Pyenson, FSA, MAAA, Jocelyn Lau, MPH, Mona Kelkar, MBA, Nancy Phillips, MD, Chi-Wei Lu, PhD, Percy Yeung, PhD, Gloria Bachmann, MD
Christine Ferro, CHFP; Bruce S. Pyenson, FSA, MAAA; Jocelyn Lau, MPH; Mona Kelkar, MBA; Nancy Phillips, MD; Chi-Wei Lu, PhD; Percy Yeung, PhD; Gloria Bachmann, MD
Stakeholder Perspective
Interventions to Reduce Avoidable Pregnancy-Related Emergency Department Visits
Eliza Ng, MD
by Eliza Ng, MD
Read More
Original Research, Practice Management
Budget Impact of Adding Vedolizumab to a Health Plan Formulary as Another First-Line Biologic Option for Ulcerative Colitis and Crohn’s Disease
Michele Wilson, MSPH, Aaron Lucas, PhD, MPH, Ann Cameron, MA, PhD, Michelle Luo, PhD
Michele Wilson, MSPH; Aaron Lucas, PhD, MPH; Ann Cameron, MA, PhD; Michelle Luo, PhD
Read More
Original Research
Assessing the Level of Patient-Specific Treatment Recommendations in Clinical Practice Guidelines for Hemodialysis Vascular Access in the United States
Gilbert L. Queeley, PhD, Ellen S. Campbell, PhD, Askal A. Ali, PhD
Gilbert L. Queeley, PhD; Ellen S. Campbell, PhD; Askal A. Ali, PhD
Stakeholder Perspective
The Challenge of Maintaining Vascular Access in Patients with End-Stage Renal Disease
Raymond L. Singer, MD, MMM, CPE
by Raymond L. Singer, MD, MMM, CPE
Read More
Original Research, Practice Management
Treatment Persistence and Healthcare Costs Among Patients with Rheumatoid Arthritis After a Change in Targeted Therapy
Machaon M. K. Bonafede, PhD, MPH, Donna McMorrow, BS, Clare Proudfoot, PhD, Shraddha Shinde, MS, MBA, Andreas Kuznik, PhD, Chieh-I Chen, MPH
Machaon M. K. Bonafede, PhD, MPH; Donna McMorrow, BS; Clare Proudfoot, PhD; Shraddha Shinde, MS, MBA; Andreas Kuznik, PhD; Chieh-I Chen, MPH
Read More
Original Research
Prior Authorization for Elective Diagnostic Catheterization: The Value of Reviewers in Cases with Clinical Ambiguity
Adam C. Powell, PhD, Stephen E. Price, DPT, MBA, Khoa Nguyen, MS, Gary L. Smith, MS, James W. Long, BSBA, Uday U. Deshmukh, MD, MPH
Adam C. Powell, PhD; Stephen E. Price, DPT, MBA; Khoa Nguyen, MS; Gary L. Smith, MS; James W. Long, BSBA; Uday U. Deshmukh, MD, MPH
Stakeholder Perspective
Standardized Documentation Can Improve Diagnostic Testing Decisions for Patients with Cardiovascular Disease
Raymond L. Singer, MD, MMM, CPE, FACS
by Raymond L. Singer, MD, MMM, CPE
Read More
Original Research
Long-Term Outcomes of a Cardiovascular and Diabetes Risk-Reduction Program Initiated by a Self-Insured Employer
Nicole D. White, PharmD, CDE, Thomas L. Lenz, PharmD, FACLM, Maryann Z. Skrabal, PharmD, CDE, Jessica J. Skradski, PharmD, Louis Lipari, PharmD candidate
Nicole D. White, PharmD, CDE; Thomas L. Lenz, PharmD, FACLM; Maryann Z. Skrabal, PharmD, CDE; Jessica J. Skradski, PharmD; Louis Lipari, PharmD candidate
Stakeholder Perspective
Influencing Patient Outcomes Through Enhanced Multidisease-Focused Interventions
Jack E. Fincham, PhD, RPh
by Jack E. Fincham, PhD, RPh
Read More
Original Research, Sleep, Practice Management
Changes in Medical Services and Drug Utilization and Associated Costs After Narcolepsy Diagnosis in the United States
Kathleen F. Villa, MS, Nancy L. Reaven, MA, Susan E. Funk, MBA, Karen McGaughey, PhD, Jed Black, MD
Kathleen F. Villa, MS; Nancy L. Reaven, MA; Susan E. Funk, MBA; Karen McGaughey, PhD; Jed Black, MD
Stakeholder Perspective
Accurate Diagnosis of Chronic Diseases Can Reduce Costs and Medical Resource Utilization
James T. Kenney, RPh, MBA
by James T. Kenney, RPh, MBA
Read More
Original Research
Delayed Treatment Acceleration in Patients with Rheumatoid Arthritis Who Have Inadequate Response to Initial Tumor Necrosis Factor Inhibitors: Data from the Corrona Registry
Dimitrios A. Pappas, MD, Robert A. Gerber, PharmD, MA, MBA, Heather J. Litman, PhD, David Gruben, PhD, Jamie Geier, PhD, Winnie D. Hua, MS, Connie Chen, PharmD, Youfu Li, MD, MPH, Joel M. Kremer, MD, John S. Andrews, MD, Jeffrey A. Bourret, PharmD
Dimitrios A. Pappas, MD; Robert A. Gerber, PharmD; Heather J. Litman, PhD; David Gruben, PhD; Jamie Geier, PhD; Winnie D. Hua, MS; Connie Chen, PharmD; Youfu Li, MD, MPH; Joel M. Kremer, MD; John S. Andrews, MD; Jeffrey A. Bourret, PharmD
Stakeholder Perspective
Limited Guidelines and Treatment Success in the Current Standard of Care for Patients with Rheumatoid Arthritis Provide an Opportunity to Inform New Treatment Protocols
Gary Branning, MBA
by Gary Branning, MBA
Read More
Original Research
Comparing Treatment Modalities for End-Stage Renal Disease: A Meta-Analysis
Gilbert L. Queeley, PhD, Ellen S. Campbell, PhD
Gilbert L. Queeley, PhD, and Ellen S. Campbell, PhD
Stakeholder Perspective
Dialysis Procedures and Health-Related Quality of Life: The Challenge of Creating Evidence-Based Healthcare in End-Stage Renal Disease
Michael F. Murphy, MD, PhD
by Michael F. Murphy, MD, PhD
Read More
Page 8 of 21
Results 71 - 80 of 210